{
    "2020-08-13": [
        [
            {
                "time": "2020-08-13",
                "original_text": "新冠抗体试剂紧急使用授权突被取消！安图生物业绩速降大股东“套现”前途凉凉 盈利能力下降",
                "features": {
                    "keywords": [
                        "新冠抗体试剂",
                        "紧急使用授权",
                        "取消",
                        "安图生物",
                        "业绩速降",
                        "大股东套现",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}